- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients.The company has 3 R&D and 5 manufacturing facilities.
Alembic Pharma announced record dates for the maturity of its Commercial Papers (CPs) totaling ₹750 Cr. If you hold these CPs, record dates fall between September 10-25, 2026, for maturities from September 11-28, 2026. This determines eligibility for your maturity payment.
Alembic Pharmaceuticals management has scheduled one-to-one meetings with various investors and analysts, including Dolat Capital, Equirus Securities, ICICI Securities, Ashmore, and HSBC, on September 1 and 2. These engagements will not involve sharing any unpublished price sensitive information.
Alembic Pharmaceuticals' management is scheduled to hold one-to-one meetings with various investors and analysts, including Dolat Capital, Equirus Securities, and HSBC, on September 1-2, 2026. These meetings will occur in Mumbai and virtually. No unpublished price sensitive information will be shared.